Literature DB >> 16571890

Oseltamivir resistance in influenza A (H5N1) infection.

Ravindra K Gupta, Jonathan S Nguyen-Van-Tam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16571890     DOI： 10.1056/NEJMc060077

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Enhanced growth of influenza vaccine seed viruses in vero cells mediated by broadening the optimal pH range for virus membrane fusion.

Authors:  Shin Murakami; Taisuke Horimoto; Mutsumi Ito; Ryo Takano; Hiroaki Katsura; Masayuki Shimojima; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

Review 2.  Designing vaccines for pandemic influenza.

Authors:  Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

3.  Residue-based design of small molecule inhibitor for H1N1, H5N1 and H7N1 mutants.

Authors:  Weng Ieong Tou; Kun-Lung Chang; Tung-Ti Chang; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  J Mol Model       Date:  2015-12-08       Impact factor: 1.810

4.  Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.

Authors:  Gallen B Triana-Baltzer; Larisa V Gubareva; John M Nicholls; Melissa B Pearce; Vasiliy P Mishin; Jessica A Belser; Li-Mei Chen; Renee W Y Chan; Michael C W Chan; Maria Hedlund; Jeffrey L Larson; Ronald B Moss; Jacqueline M Katz; Terrence M Tumpey; Fang Fang
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240

5.  Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein.

Authors:  Gallen B Triana-Baltzer; Larisa V Gubareva; Alexander I Klimov; David F Wurtman; Ronald B Moss; Maria Hedlund; Jeffrey L Larson; Robert B Belshe; Fang Fang
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240

6.  A Validated HPLC Method for Zanamivir and its Application to In vitro Permeability Study in Caco-2 Culture Model.

Authors:  B Boonyapiwat; N Sarisuta; Y Ma; G B Steventon
Journal:  Indian J Pharm Sci       Date:  2011-09       Impact factor: 0.975

Review 7.  Developing Infectious Disease Strategies for the Developing World.

Authors:  Paul J Lee; Leonard R Krilov
Journal:  Annu Rep Med Chem       Date:  2007-01-26       Impact factor: 1.059

Review 8.  What the paediatrician needs to know when pandemic influenza arrives in clinical practice.

Authors:  Nicole Ritz; Nigel Curtis
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

9.  An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.

Authors:  Mengdie Ye; Yixian Liao; Li Wu; Wenbao Qi; Namrta Choudhry; Yahong Liu; Weisan Chen; Gaopeng Song; Jianxin Chen
Journal:  Viruses       Date:  2020-02-18       Impact factor: 5.048
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.